|Articles|February 12, 2008
CEO of Genelabs Resigns
Author(s)BioPharm International Editors
James A.D. Smith, president, chief executive officer, and director of Genelabs Technologies, Inc. (Redwood City, CA) has resigned.
Advertisement
James A.D. Smith, president, chief executive officer, and director of Genelabs Technologies, Inc. (Redwood City, CA) has resigned. Until a successor is appointed, Irene A. Chow, executive chair of Genelabs’ board of directors, and Frederick W. Driscoll, CFO, will assume leadership responsibilities.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Developing Next-Gen Cell Lines Using Targeted Integration
2
FAQ: What You Need to Know about the Current Antibody Pipeline
3
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
4
Norgine Secures Hepatitis Delta Therapy Rights Across Key Region
5